Trevor James
The Bacille Calmette-Guérin (BCG) vaccine is a tuberculosis (TB) vaccine that has been around since the 1920s. It is widely used in over 180 countries and is given to infants and young children to protect them from severe forms of TB, such as TB meningitis. In some countries, the BCG vaccine is routinely administered to newborns, especially in areas with high TB rates. However, the vaccine is not routinely used in the United States and some other developed countries due to the low incidence of TB. While the BCG vaccine is generally safe, its effectiveness in protecting against TB is mixed, and it does not always prevent infection.
| Characteristics | Values |
|---|---|
| Name of the vaccine | Bacillus Calmette-Guérin (BCG) |
| Countries where BCG is routinely administered | Over 180 countries including South Africa, the Philippines, Hong Kong, Japan, and the UK |
| Countries where BCG is not routinely administered | The United States, the Netherlands |
| Who is the BCG vaccine recommended for? | Children with a high risk of developing TB, children with weakened immune systems, children living with someone infected with TB, children travelling to countries with high rates of TB, healthcare workers |
| How is the BCG vaccine administered? | As a shot or injection in the upper arm |
| How many doses are required? | Only 1 dose is required |
| When is the BCG vaccine administered? | At birth or when the baby is around 28 days old |
| Effectiveness | Evidence of effectiveness in protecting against TB is mixed. The vaccine is only effective in preventing severe disease in children under 5. |
| Side effects | Permanent scar from the injection, chance of having a positive TB skin test in the future |
| Tests | Tuberculin skin test, Mantoux test, TB blood test |
Explore related products
What You'll Learn
- The BCG vaccine is a shot in the upper arm to infants just after birth
- The TB vaccine is good at protecting against the severe form of the disease found in young children
- The TB vaccine is rarely used in the US and is only recommended for children living with someone infected with TB
- The TB vaccine is mandatory in some countries but is controversial due to its mixed effectiveness
- The TB vaccine can cause a false positive TB skin test reaction
The BCG vaccine is a shot in the upper arm to infants just after birth
The BCG vaccine, short for Bacillus Calmette-Guérin, is a vaccine for tuberculosis (TB). It is made from a weakened strain of bacteria similar to tuberculosis, called Mycobacterium bovis, which is similar enough to the human strain (Mycobacterium tuberculosis) to be effective in vaccination.
The BCG vaccine is typically given as a shot in the upper left arm to infants just after birth, usually around 28 days old. It is recommended for babies and young children who are at a higher risk of getting TB, such as those with weakened immune systems or those living with someone infected with TB. The vaccine is particularly effective in protecting against more severe forms of TB, such as TB meningitis, which can be deadly if left untreated.
In most countries where TB is endemic, the BCG vaccine is routinely given to infants to prevent severe TB. However, in countries like the United States and the Netherlands, the BCG vaccine is not routinely used due to the low incidence of TB. Instead, other measures are taken to stop the spread of TB, such as regular skin tests and antibiotic treatment for those infected.
While the BCG vaccine is effective in protecting against severe TB, it is important to note that it does not always prevent people from getting TB. Additionally, the protection offered by the vaccine weakens over time. As such, it is important to consult with a healthcare provider to determine if the BCG vaccine is suitable for your specific circumstances.
Vaccination Scars: What's the Story Behind the Mark?
You may want to see also
Explore related products
The TB vaccine is good at protecting against the severe form of the disease found in young children
The Bacille Calmette-Guérin (BCG) vaccine is a vaccine for tuberculosis (TB) disease. It is not generally used in the US, the Netherlands being the other country that has never routinely used it. This is because miliary TB, the severe form of the disease found in young children, is very uncommon in the US. However, the BCG vaccine is effective at preventing tuberculosis in young children. It is mainly given to babies and young children who are at higher risk of getting TB.
The BCG vaccine is particularly helpful in protecting babies and young children against more serious forms of TB, such as TB meningitis (TB that affects the brain). It can also cause TB meningitis, particularly in children, spreading to other parts of the body, including the meninges. TB meningitis is a severe, often fatal form of TB that spreads to many parts of the body. Those under five years old are susceptible to this form of TB, which can be fatal.
The BCG vaccine is a live vaccine, which means it contains a weakened form of the TB bacteria and is not suitable for everyone. It is not recommended for babies who may have a weakened immune system, for example, due to a family history of HIV or severe combined immunodeficiency (SCID). Children and adults with weakened immune systems, either because of a health condition or treatments such as chemotherapy or steroid tablets, should also refrain from taking the vaccine.
The BCG vaccine is given as a single shot or injection into the upper part of the left arm. You only need one dose. However, the vaccine's protection weakens over time, and protectiveness may begin to wane as children get older. Thus, children over ten years old and adults should receive a booster BCG vaccine and eventually a new supplemental vaccine.
When Do I Achieve Full Vaccination Status?
You may want to see also
Explore related products
The TB vaccine is rarely used in the US and is only recommended for children living with someone infected with TB
The BCG vaccine, or tuberculosis (TB) vaccine, is rarely used in the United States. This is because TB is not as contagious as other diseases, and it is usually obvious when someone has active TB. The US has also seen a slow decline in TB cases since 1993, likely due to better control of HIV with the use of anti-retroviral drugs.
The TB vaccine is primarily used in countries where TB is more common, such as in Southeast Asia, sub-Saharan Africa, and the former Soviet Union. In these countries, the BCG vaccine is often given to infants and young children as they are at higher risk of getting TB. The vaccine helps protect against severe forms of TB, such as TB meningitis, which can be serious if untreated.
In the US, the CDC recommends the TB vaccine only for those with a high risk of developing TB. This includes children who live with adults who have untreated, ineffectively treated, or drug-resistant TB. The vaccine is also considered for healthcare workers who are regularly exposed to patients with drug-resistant TB.
The TB vaccine is given as a single shot and is safe, but its effectiveness in protecting against TB is mixed. While it can help protect against severe forms of TB in young children, it is not as effective at preventing the lung infection commonly found in adolescents and adults. The vaccine's protection also weakens over time, and it can cause false positive results on TB skin tests.
Decisions regarding the TB vaccine for children in the US are typically made in consultation with a local TB control program or a TB expert.
mRNA Vaccines: The Future of Medicine?
You may want to see also
Explore related products
The TB vaccine is mandatory in some countries but is controversial due to its mixed effectiveness
The Bacille Calmette-Guérin (BCG) vaccine, or tuberculosis (TB) vaccine, is mandatory in several countries, especially those with a high incidence of TB cases. It is typically administered to infants just after birth or when they are around 28 days old. The vaccine is also recommended for children and adults with a high risk of TB exposure, such as those with a weakened immune system or those who are regularly in contact with people infected with TB.
While the BCG vaccine is effective at preventing severe forms of TB in young children, such as TB meningitis and miliary TB, its effectiveness in adolescents and adults is less consistent. Studies have shown mixed results, with the vaccine being only 18% effective overall in protecting against TB and related complications. The variable efficacy of the BCG vaccine may be due to factors such as BCG strain and previous exposure to environmental mycobacteria.
In the United States, the BCG vaccine is not routinely used and is only considered for individuals with specific risk factors for TB. This is partly because the risk of TB in the United States is relatively low, and the benefits of vaccination may not outweigh the potential downsides. Additionally, the TB vaccine can cause false-positive results on tuberculin skin tests, complicating treatment plans and leading to confusion.
The controversy surrounding the mandatory BCG vaccination stems from the mixed evidence of its effectiveness and the varying vaccination policies and practices across different countries. While some countries continue to vaccinate newborns, others have shifted their focus to developing more effective vaccines or implementing selective deferral of BCG vaccination in certain populations, such as infants exposed to HIV.
Despite the controversy, the BCG vaccine remains an important tool in the fight against TB, especially in countries with a high burden of TB cases. However, there is a growing consensus that a more consistently effective vaccine is needed to achieve the World Health Organization's 'End TB strategy'.
The Elusive HIV Vaccine: Why the Challenge?
You may want to see also
The TB vaccine can cause a false positive TB skin test reaction
The TB vaccine can cause a false-positive TB skin test reaction. The TB skin test, also known as the tuberculin skin test, is a test for tuberculosis (TB) infection. It involves injecting a small amount of testing fluid called tuberculin under the skin using a needle. After two to three days, a healthcare provider will measure the size of the bump or reaction. A positive or negative result depends on the size of the bump.
The TB vaccine, known as the BCG vaccine, is given to infants and small children in countries where TB is common. It protects children from getting severe forms of active TB, such as TB meningitis. However, the BCG vaccine may cause a false-positive reaction on a TB skin test. This means that the test indicates the presence of TB germs in the body, even though the person is not actually infected with TB bacteria.
There is no reliable way to distinguish between a positive TB skin test reaction caused by the BCG vaccine and one caused by a true TB infection. For this reason, it is recommended that individuals who have received the BCG vaccine undergo a TB blood test instead of a skin test. TB blood tests are not affected by the TB vaccine and are the preferred method of testing for people who have been vaccinated.
It is important to note that a positive TB skin test or blood test does not necessarily mean that a person has an active TB infection. It only indicates that they have been exposed to the TB bacterium. Further tests, such as a chest X-ray or sputum test, are needed to determine whether the infection is active or latent.
In summary, the TB vaccine can cause a false-positive reaction on a TB skin test, leading to incorrect interpretations of TB infection. To avoid this, individuals who have received the TB vaccine should inform their healthcare provider and undergo a TB blood test instead.
Wart Vaccines for Cattle: Are They Available in the US?
You may want to see also
Frequently asked questions
The TB vaccine, also known as the Bacillus Calmette-Guérin (BCG) vaccine, helps protect against tuberculosis (TB). It is made by weakening a strain of bacteria similar to tuberculosis.
The BCG vaccine is mainly given to babies and young children who are at a higher risk of getting TB. It is also recommended for people who have recently moved to a country with high TB rates from a country with low TB rates.
The TB vaccine is good at protecting against severe forms of TB found in young children, such as TB meningitis. However, it is less effective at protecting against the lung infection commonly found in adolescents and adults.
